Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,695
Closed -$304K 542
2025
Q2
$304K Buy
+9,695
New +$321K 0.03% 401
2024
Q4
Sell
-15,103
Closed -$650K 445
2024
Q3
$650K Buy
+15,103
New +$673K 0.08% 257
2023
Q4
Sell
-6,856
Closed -$362K 490
2023
Q3
$362K Buy
+6,856
New +$400K 0.03% 376
2023
Q2
Sell
-11,755
Closed -$629K 426
2023
Q1
$629K Buy
+11,755
New +$681K 0.06% 318
2021
Q3
Sell
-302
Closed -$24K 506
2021
Q2
$24K Buy
+302
New +$23.1K ﹤0.01% 804
2021
Q1
Sell
-4,610
Closed -$303K 867
2020
Q4
$303K Buy
4,610
+2,522
+121% +$147K 0.05% 413
2020
Q3
$113K Buy
2,088
+992
+91% +$54.5K 0.07% 277
2020
Q2
$53K Buy
+1,096
New +$48.4K 0.02% 628

Other funds holding ENOV

FORA Capital's ENOV Position: Q3 2025 in Review

FORA Capital sold out of Enovis (ENOV) in Q3 2025, closing a stake of 9,695 shares — an estimated $304K sold.

FORA Capital first reported a position in ENOV in Q2 2020 and held it in 8 quarters. The position peaked at $650K in Q3 2024. 278 funds tracked by Wall St. Rank hold ENOV as of Q3 2025.

  • FORA Capital reported no remaining Enovis position as of Q3 2025 after selling out during the quarter.
  • FORA Capital sold 9,695 Enovis shares in Q3 2025, an estimated $304K.
  • FORA Capital first reported a position in Enovis in Q2 2020 and held it in 8 quarters.
  • FORA Capital's Enovis position peaked at $650K in Q3 2024.
  • 278 funds tracked by Wall St. Rank held Enovis as of Q3 2025.

Based on FORA Capital's 13F filing for Q3 2025, filed 13 Nov 2025.